6634 ªYÄ£
ªÑ¥»: 3.832»õ
¥Dn·~°È:
¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo
¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤)
¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤)
Ä~Äò©¹¤U¬Ý...!
=============================================================================
²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ)
¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢
²£«~Àu¶Õ:
1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ«
2.¥«³õº¨£·sÃÄ(First-in-class)
3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x
4.µL¦w¥þ©Ê°ÝÃD
¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C
Ävª§¤O:
1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢
2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯×
3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x
¬ãµo¶¥¬q:
1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á
2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ
Àø®Ä¤ÀªR¡G
1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n
2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009)
=============================================================================
²£«~02¡GSNP-630
¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢
²£«~Àu¶Õ:
1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE)
2.¥«³õº¨£·sÃÄ(First-in-class)
3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x
4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~
¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C
Ävª§¤O:
1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢
2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯×
3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡
4.µL¦w¥þ©Ê°ÝÃD
¬ãµo¶¥¬q:
1.Á{§É«e
2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C
3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C
Àø®Ä¤ÀªR¡G
1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05
=============================================================================
²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯)
¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯)
²£«~Àu¶Õ:
1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê
2.¸Ñ¨M¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs)
3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q
¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ
Ävª§¤O:
1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«
2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^
3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O
¬ãµo¶¥¬q:
1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç
2.¤w¥Ó½ÐUSFDA¼Ï纽Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D
3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç
=============================================================================
²£«~04¡GSNP-830/ SNP-840
¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B««×¯kµh)
²£«~Àu¶Õ:
1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è
2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q
¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ
Ävª§¤O:
1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è
2.½Æ¤è¤w¥Ñ¬ü°êFDAn¨D°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä
3.¦³¨Ï¥Î±M§Q¡A¥iקï©Î§R°£FDA¨x¬rĵ»y
4.¥i¼W¥[¤AñQÓi×ô¾¯¶q
¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A°§C¦¨Å}°Æ§@¥Î
5.¤GªÌ¾Ü¤@±ÂÅv
6.¥i¼W¥[¥«¦û²v
¬ãµo¶¥¬q:
1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç
SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ýn¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç
µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ
=============================================================================
*****************************************************************************
SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G
1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005
1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005
=============================================================================
*****************************************************************************
¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G
1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv
2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv
3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv
=============================================================================
*****************************************************************************
¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@p¹º
§Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó
¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ùȱo´Á«Ý¡A¦³¾÷·|¬O ¤U¤@Ó ¦X¤@ ÄƪÑ
-----------------------------------------------------------------------------
¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×)
¼v¤ù8¤À~
JP:....§Úªº»ù¿ú¨S¦³¤ñpanadol¶Q³á...¤]¨S¦³¤ñTylenol¶Q³á.....
------------------------------------------------------------------------------------
SNP-810¸Ñ¨M¤FAPAP¨x¬r©Ê¡A»ù¿ú¤´¥i«K©y!
www.facebook.com/watch/?v=3194947797458964
1.JP¦³±j½Õ¬O[¤G´Á¹ï¤G´Á]µ²ªG¡C
2.6¨t¦C¬OÂù¹vÂI:CYP2E1 »P DGAT1¡C
3.Ó¤H¤£t³d»{¬°SNP-810±ÂÅv»ùȤ£¦b«D³B¤èÃÄOTC¡A¦Ó¦b³B¤èÃÄ¥«³õ¡C
¦n¹³¨S¦³¥¼¨Ó¡H
8¨t¦C±ÂÅvª÷ÃB§Ú¤]¨S¦³¼ÖÆ[¨ì¤W¬Ý5»õ¬ü¤¸¡Apublic health ÃļtÄ@·N¥I¦h¤Ö¿ú©O? OTCÃĨS³q¸ô¡A¨S¼s§i = 0 »ùÈ
n¨ú¥N´¶®³¯k§¹¥þ¬O¦b§@¹Ú¡C
R¤j
³o´N¬O§Ú©Ò»¡ªº¡u³o¼Æ¾Ú¦pªG¬O¯uªº¡v
M¤½¥qªÑ»ù¦³¶]¨ì310¬ü¤¸
ªYÄ£¥Ø«e¬O3¬ü¤¸¦h
è¦n¬O¤H®a§À¼Æªº¹sÀY
³sC¤½¥q¶i«×¸¨«áªYÄ£¡A³£¦³11¬ü¤¸¡C
ÁÙ¬O¨ì¨º´µ¹F§J¤W¥«§a¡I
2023.1.19-FDA ±µ¨ü INTERCEPT ªº OCA ·sÃĥӽСA¥Î©óªvÀø NASH ¤Þ°_ªº¨xµw¤Æ«e´Á¨xÅÖºû¤Æ(PDUFA ¥Ø¼Ð¦æ°Ê¤é´Á³]©w¬°2023¦~6¤ë22¤é)
------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/18 ¤W¤È 07:49:34²Ä 1600 ½g¦^À³
·Q[½ä]¤@©]P´I?³o®aIntercept pharmaceuticalsªº[²×§½¤§¾Ô]¦³¼Éº¦10~20¿ªº¹ê¤O»P¾÷·|?!
ì¦]:
...
...
4.Ó¤H¤£·|©ãª`³o³õ½ä§½¡A°lÂÜFDA§å㪺²Ä1¤äNASHÃĪ«¥Î¡C
108/07/24 Bio-Asia¨È¬w¥Í§Þ¤j®iÁ|¿ì¤§¤½¥q®i±æ»¡©ú·|:SNP-6Àø®Ä¦w¥þ©ÊÀu©ó«eªuªºMadrigal MGL-3196¡C
¬Q¤éMadrigal¥«È21.83»õ¬ü¤¸(³o®a¤½¥q¤]´N2¤äªvÀøNASHªºÃĪ«MGL-3196(P3) /MGL-3745(Á{§É«e)¥~¡A§OµL¥Lª«!) www.madrigalpharma.com/ourapproach/pipeline/
¥Ø«eªYÄ£¥«È¤£¤ÎMadrigalªº10%!
-------------------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/22 ¤U¤È 07:13:12²Ä 2748 ½g¦^À³
·|û¡GROGER588910148151 µoªí®É¶¡:2022/12/21 ¤U¤È 08:39:13²Ä 2746 ½g¦^À³
¤@¥¹¦¬ÁÊ»ù¯}¦Ê»õ¡ANASHÃĪ«¦b2023¦~§óºë±m!
Speculation is already building among industry observers that the company could become a takeover target, perhaps garnering as much as $9 billion.
----------------------------------------------------------------------------------------------------
MadrigalÀ³¸Ó½æ¶Ü¡H
...µØº¸µó¦ôp¡A³oÓ©|¥¼¶}µoªºÃÄ«~¥«³õ¨C¦~¥i²£¥Í¶W¹L 350 »õ¬ü¤¸ªº¾P°âÃB¡C
... MDGL ¬°¤°»òn¥H°Ï°Ï 100 »õ¬ü¤¸ªº»ù®æ¥X°â¦Û¤v¡H
°Ï°Ï100»õ¬ü¤¸ªº»ù®æ¬O½â½æ¤F? Orz.
----------------------------------------------------------------------------------------------------
¥Ø«eMadrigal¥«È51.58»õ¬ü¤¸¡AªYÄ£¥«È¬OMadrigalªº5%!
«ø¥Ø¥H«Ý°ê»Ú¤j¼t·|¤£·|¶}¥X°ª©ó100»õ¬ü¤¸¦¬ÁÊMadrigal???
¶Ê«P¤½¥q¥[§Ö¸ÕÅç³t«×
¤£ºÞ¬O810¡B610¡B630³£n§Ö°¨¥[Ã@ªº§¹¦¨
NASH²Ä¤@¦W¶i«×¦h¦¸¯¸¤W3¦Ê¬ü¤¸
A¤½¥q2b´Á¤¤³ø§i«á³£¦b50¬ü¤¸ªþªñ±r«Þ
ÁÙ¦³«Øij¨ì¨º´µ¹F§J¤W¥«
ÃĮįu¦p¤½¥q©Ò¤½§iªº¼Æ¾Ú
¦Ü¤Ö¤]È20-30¬ü¤¸
JP ªº²Ä¥|¡B²Ä¤¦Wµ¦²¤¤£²Å¦X°Ó·~Ävª§¤O
©Ò¥H²{¦bªºªÑ»ù¥u¦³²Ä¤@¦Wªº¹sÀY-3¬ü¤¸
¯uªº¥Í§Þ¤½¥qÅý¤H¬Ý¤£À´¡H©Ò¥H«Ü¦h¤H³£¤£·P§ë¸ê¥Í§Þ¤½¥q¡C
§Ú²{¦b¶R¶i´N¥´ºâ«ù¦³2-3¦~.
©Î³\n¬Ý¤@¤U«e¤å
¤~¯à¤F¸Ñ¡uªYÄ£¡vªº°ò¥»±
Ȥ£È±o§ë¸ê¡I
R¤jªº´£ÂI¡G¤j¼tªº·Ð´o¡A´N¬OªYÄ£ªº¾÷·|¡C
2023.1.11-¼Æ¥H¦Êpªº¡§®õ¿Õ¶D³^¡¨ÁnºÙ¹s°â°Ó¡B»s³y°Óª¾¹DÃh¥¥´Á¶¡¹ï¤A酰®ò°ò×ô¥i¯à¾ÉP¦Û³¬¯g¡B¦h°Ê¯gchildrenshealthdefense.org/defender/tylenol-lawsuits-acetaminophen-pregnancy-autism-adhd/
...¹wp±j¥Í¤½¥qÁÙ±N¦]¯A¶û¹ªÀy¦bÃh¥¥´Á¶¡¼sªx¨Ï¥Î¹ï¤A酰®ò°ò×ô¦Ó´£°_¶D³^¡A³o¥i¯à·|¨Ï³o¤@¼Æ¦r¹F¨ì¼Æ¤d¤H¡C
--------------------------------------------------------------------------------------------------
°ü¤kÃh¥¥´Á¶¡½w¸Ñ¯kµhªº¿ï¾Ü«Ü¤Ö¡AAPAP¬O¬°¼Æ¤£¦hªº³q±`³Q»{¬°¥i¥H¦bÃh¥¥´Á¶¡¦w¥þªA¥Îªº¤îµhÃĤ§¤@¡C¥¦Àu©ó«DÍrÅéÃþ§Üª¢ÃÄ (ªü¥q¤ÇªL¡B¥¬¬¥ªâ©M萘´¶¥Í)¡A«áªÌ¤w³QÃÒ©ú·|³y¦¨§³®W·ÀI¡A¨Ò¦p¦Ï¤ô¹L¤Ö©ÎL¨àµÇŦ°ÝÃD¡C
2020.10.15-¬ü°êFDAºô¶
www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later-because-they-can-result-low-amniotic
«Øij¥¥°ü¦b 20 ¶g«á¤£nªA¥Îªü¥q¤ÇªL¡B¥¬¬¥ªâ©M萘´¶¥Íµ¥«DÍrÅé§Üª¢ÃÄ¡A¦]¬°³o¥i¯à·|¾ÉP¦Ï¤ô¹L¤Ö¡C
¸ÕÅç¦aÂI¦b»OÆW
¸ÕÅçp¹º¤º®e
³£»PSNP-610-201¸ÕÅçp¹º¤º®e¬Û¦ü
¤£ª¾¹D¬°¤°»ò·|¦³SNP612ªº¦WºÙ¡H
¦Ó¥B¬O¥X²{¦b¸Ó©xºô¯¸¡I
ÁÙ¦³1¤äSNP-612¡A²ö«D¬OSNP-630ªº³¶ù¤XøU¡A¦a¦ì¤£«n?
¥xÆWÃĪ«Á{§É¸ÕÅç¸ê°T¥¥x¬d¤£¨ìSNP-612(¤½¥qºô¶¤]¨S³o¤ä)....
--------------------------------------------------------------------------------------
·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/9 ¤U¤È 09:31:39²Ä 85 ½g¦^À³
SNP-630 ·|¤À¸Ñ¬° 3 Ó¬¡©Ê¥NÁª«¡A¨ä§@¥Î©ó NASH ¾÷Âà»P¥ÀÃĬۦü¡A±©¨äÃIJz¬¡©Ê§¡§C©ó SNP-630¡C
--------------------------------------------------------------------------------------------
SNP-630¥NÁª«:SNP-610 / SNP-612(?) /SNP-620(?)
Recruitment Status : Terminated (recruitment difficulties due to Covid-19)
First Posted : March 11, 2019
Last Update Posted : January 6, 2023
www.clinicaltrials.gov/ct2/show/NCT03868566?term=sinew+pharma&draw=2&rank=4
¨S¦³¬Ý¨ìªü ·PÁÂ~~
½Ð°Ý¦³¤Hª`·N¨ì104¦b¼x½]®Ö¥DºÞ¡A¬Ý¨Ó¥i¯àn´«¤H¡H¬O§_¤WÂd©µ«á¾÷²v¼W¥[¡H
810®³¨ì¬ü°êOTCÃÄÃÒ«á¡A±q¥H«eªº¡u¦X§@¨óij¡v§ï¬°¡u±ÂÅv¡v¡C
¡u±ÂÅv¡v¬O§_²{¦b¥¿¦b¬¢½Í¤¤¡H
810¼Ï¶s¸ÕÅç¡A®³¨ì³B¤èñÃÄÃÒ«án¡u¦Û¾P¡v¡C
±ÂÅvª÷ÃBµø¥«³õ³W¼Ò¡I
610¦n¹³¨S¦³§ïÅÜ
¤£±µ¹q¸Üªº²z¥Ñ«Ü¦h¡A©Ç¤£±oªü©f¡A¦Y¤HÀY¸ô¡AÁ`n¿í±q¦ÑÁó«ü¥Ü¡C
610¸ÕÅç¯f±w¡A·íµMn²Å¦X¤@©w±ø¥ó¤~¯à¦¬®×¡C
¤£¹L¡A2b¦¬®×¤H¼Æ¤]¤£¦h¡A«½à¤§¤U ¥²¦³«i¤Ò¡C
µ¹°t¦XªºÂå°|¦hÂIÃB¥~³ø¹S¡A¦¬®×³t«×·|§Ö¤@ÂI¡C
´N¬O¬Ý¥D¨ÆªÌªº·Qªk¡B°µ¬°¡A¦pªG¬O¥H°Ó¤Hªº§Q¯q¨Ó¬Ý«Ý¡AºA«×·|¿n·¥¡C
810¼Ï¶s¤H¼Æ¤]¤Ö¡A¥B¸ÕÅç¹ï¶H«D±`¦n§ä¡A¤H®aµ¹2¸U¡A¤½¥qµ¹3¸U¡A¤£¥X´XÓ¤ë´N¥i¥H°µ§¹¡C
¥un¼Ï¶s¹F¼Ð¡A³B¤èñÃÄÃÒ´N««¤â¥i±o¡C
¤j¼tªº¦X§@¨óij¤£¬O§ó¦³§Q¶Ü¡H
¹D²z´N¬O³o¼Ë²³æ¡I
±z·Q¡H
ªYÄ£ªºªÑ»ùÁÙ·|¦b³o¸Ì°²V¶Ü¡H
¦¶³Í¥Áªí¥Ü...¦P®É±N¥[³t¯×ªÕ¨x·sÃÄSNP-610¶}µo¡Aº¥ý±NÂX¼W1¿ªº¬ãµo¤Hû
---------------------------------------------------------------------------------------------
¬O¦³n¥[§Ö¶}µoªº¸}¨B(±NÂX¼W1¿ªº¬ãµo¤Hû)¡A¦ý104¤Wªº¨xŦ¯e¯f¬ãµo³B»P¯kµhÃĪ«¬ãµo³B¤w¶K¦n¤[¡A¦n¹³§ä¤£¨ì¬ÛÃö¤Hû?
¸³¥Jªº¸¹½X¦b§Ú¤â¾÷ºLÃa´«·s®É¤£¨£¡A§Ú¤]§ä¤£¨ì¤H°Ý...
ªÑªF¤j·|®É´£®×
Àµ½ÐªYÄ£¨ì¬ü°ê¨º´µ¹F§J¤W¥«
¦Ü¤ÖªÑ»ù¤]¦³1-20¤¸¡A¤£·|¹³²{¦b¤~3¶ô¦h¡C
¦Ó¥B¡Aª¾¦W«×¤]¸û°ª¡I
³Ñ¤U3¤Ñ«ÊÃö¡Aè¦n¬OR¤j©Ò´£°¨¶³¡G¤µ¤Ñ«Ü´Ý»Å ©ú¤Ñ§ó´Ý»Å «á¤Ñ«Ü¬ü¦n ¦ý¤j³¡¤À¤H¦º¦b©ú¤Ñªº±ß¤W!!°¨¶³¤Ó½Ä°Ê´±©M²ß¤j¹ï·F¡A¤H³£®ø¥¢¡AªÑ²¼¤]®ø¥¢¡C(ÁÙ¦n°¨¶³¤£»{ÃÑ¿ú¬O¤°»ò)
µoÓ¤j¬õ¥]§a~~~
¦¶¸³®Ú¥»¤£·Q±µ¹q¸Ü
¤u·~§½ªº¦P·N¨ç´Á¨ì3¤ë¤U¦¯
¦pªG¶W¹L´Á¥¼´£¥X¤WÂd¥Ó½Ð
´N¦³±oµ¥¤F
-----------------------------------------
³Ìªñ¦³¤H¥h¹q¤½¥q°Ý¹L±ÂÅv»P¤WÂd¶i«×¶Ü?
madrigal stock
2022.12.5 °ª83¤¸¡A7±þ¨ì2022.12.14§C57.21(¦¬58.39)¡A3¤Ñ«áªº¶g¤@2022.12.19¤jÃzº¦!
-----------------------------------------------------------------------------------------------------
°¨¶³¡G¤µ¤Ñ«Ü´Ý»Å ©ú¤Ñ§ó´Ý»Å «á¤Ñ«Ü¬ü¦n ¦ý¤j³¡¤À¤H¦º¦b©ú¤Ñªº±ß¤W
Js¾Ç³N¤W¬O¼·¡¡A¦ý§ë¸ê´N¤£¤@©w¤F(¤½¥q¤]¨Sµ¹¥LªÑ²¼¡A¦Û¤w¦³¨S¦³¶R´N¤£ª¾¹D¤F)¡A§Úı±o¤ßµ|¤]¬O°]°È¤Wªº°ÝÃD³y¦¨¤µ¤éªº§½±¡A¦ý¤£±Æ°£¬O¥D¤O³Î´µæ¡C
·sÄ£¤µ¤Ñ¤S¯}¦Ê¤F@@¡C«á¨Ó°l¦^ªº¤S®M¤F¡C½u«¬¤W¤]¤£¨Î¡C
¥Í§Þ³oªi¥»¨Ó´N®z¡A¦X¤@¤]gg¡C¤TÓ¤ë¤S¤TÓ¤ë¡A¨C¦¸·s»D¤j¶i«×¤p¡C
¤½¥q¦~³ø¦³Madrigal ªº3´Án¨ì2024¦~
¤H®a¦b¥h¦~2022¦~©³¤½¥¬3´Á¡A¬Ý¬Ý¤H®aªº¿n·¥ºA«×¡C
¦A¬Ý¬ÝªYÄ£ªºÀt¨B°µªk¡A¤j®a¤@°_¶Ê«P¤½¥q¥[§Ö¸ÕÅç³t«×¡C
¥ú¬O¼Ï¶s¸ÕÅç¤~´X¤Q¤H¡A¥l¶Ò¸ÕÅç¹ï¶H¨C¤Hµ¹3¸U¬ü¤¸¡C
¾a¸y¡A¨S´XÓ¤ë´N°µ§¹¤F¡AÁÙ·d¨º麽¤[¡H
¨ä¹ê¤ÏÆ[2022¦~¡A¤j½L¥§¡³£¬O-20%¡K§ë¸ê¬üªÑ§ó¬O-40%
¦p¦P½²¤j»¡ªº¡K ¥H¼W¸ê»ù75¶ô¨Ó¬Ý¡K¾ã¦~ÁZ®ÄÁÙ¬O+20¥H¤W¡K ¨S±o¬D¤F
·sÃħë¸ê§Ú¬O©ê«ùµÛ¥H¦~¬°³æ¦ì¡K3-5¦~°ò¥»ªº¡K®M¥y¸ô¸³»¡ªº¡K¤Q¦~¿i¤@¼C¡A»P¤j®a¦@«j
¤îµhÃÄ¥«³õ¬OÃe¤j¡A¦ý¤p¼t¦æ¾P¬O«Ü§xÃøªº¡C
¤j¼t¦³°ªª¾¦W«×¡A¦³Ãe¤jªº³q¸ô¡C
´N®³³o¦¸¡u´¶®³¯k¡v¤§¶Ã¨Ó»¡¡A®Ú¥»¤£¯Ê¤AñQÓi×ôªºÃÄ¡C
¦ý¤j²³¥u»{¡u´¶®³¯k¡v¡I
»P¤j¼t¦X§@¤~¬O³Ì¨Î¿ï¾Ü¡I
³B¤èñªºÃÄÃÒ³\¥i¡A¤À¼í·|¸û°ª¡C
¦ý¬O¡A¤½¥q¸ÕÅç¶i«×¹³¯QÀt¤@¼ËºCºCºCºCºCºC¨ì¤£¦æ¡I
NASH¤]¬O¤@ӼˡAºC¨ì¤£¦æ¡C
Ó¤H«D±`¤£»{¦PJ±Ð±Âªº·Qªk¡A¤£·m²Ä¤@¡A¦Ñ¥|¡B¦Ñ¤³£¦æ¡C
§L¶Q¯«³t¡A¾ÇªÌ»P°Ó¤Hªº·Qªk¡B°µªk³£¤£¦P¡C
¤µ¤Ñ¦pªGªYÄ£NASH2b¤w§¹¦¨¡AªÑ»ù¦´N¥h°lAkero ¤F¡C
²{¦bªº²Ä¤@¦WMadrigal ªÑ»ù£¸ª½¬D¾Ô3¦Ê¬ü¤¸
³o´N¬O²Ä¤@¸ò·Q·í¦Ñ¤ªº®t§O
³oOTC¯uªº¤£¤Ó»¡A¥[¤WµL¬r¡A¥D¤O¬Ý¤£¤W~~
========================================================================
³£¦³³\¥i¤F ÁÙ¤£»¶Ü?
¨ì©³¦bµ¥¤°»ò ¥xªÑ¬P´Á¤@¤Sn³Q¬üªÑ¸õ¤ô¼v¦V ¤pģģ·|¤£·|¶^¯}120©O??
=============================================
¦³¤@¨Æ¤@ª½¤£¸Ñ¡G¸³¨Æªøªí¥Ü¡A¸Ó¤½¥q¶}µoªºµL¨x¬r©Ê¤AñQÓi×ô¤îµh·sÃÄSNP-810¡AÀò¬ü°êOTC ³\¥i¡A¤w¨ú±oNational Drug Code¡]°ê®aÃÄ«~ÅçÃÒ¸¹¡^¤Î¬ü°ê¥«³õ¾P°â¸ê®æ¡C
¤jÃļt±ÂÅvª÷°ª¡A¾P°â¶q¤j¤S¯à°¨¤W¥Îì¨ÓÃÄÃÒÄ~Äò¾P°â¡Aµ¥·sÃÒ¤U¨Ó¦A´«ÃÒ¡A¤À¼íª÷¤]°¨¤W¦³¡A³o¬O¤½¥q±ÂÅvº¿ï²{¦b¦X§@¤j¼tì¦]¡F¬Û«H©¼¦¹¦X§@¨Ã¥BÂX¤j¦X§@¤~¬OºÍ´¼¡C
¥t¥~¡A¤£ª¾¹D¤j®a¦³¨S¦³µo²{¡A¥«³õ¦b½Í½×·sÃĶ}µo©Î±ÂÅv¶i«×®É¡A´X¥G«Ü¤Ö½ÍÈЪYÄ£ÈСAì¦]¬O¤°»ò¡H¤£¬Ý¦n¶Ü?
2023¦~1¤ë3¤é ¶g¤G ¤U¤È9:17
²{¥N·Òªo2¤é«Å¥¬¡Aµoµ¹û¤u1000%ªº¦~²×¼úª÷¡A¦ý¤½¥q©Úµ´³zÅS¨ãÅéª÷ÃB¡A¥h¦~û¤u®³¤F600%¦~²×¼úª÷¡A¥§¡¨C¤H7.26»õÁú¤¸¡]¬ù·s¥x¹ô1760.8¸U¡^¡C¾Ú¤F¸Ñ¡A²{¥N·Òªo·|µ¹¥X³o»ò¥iÆ[ªº¦~²×¼úª÷¡A¬O¦]¬°·Òªo¦æ·~¥h¦~ªº¥X¦âªí²{¡A²{¥N·Òªo¦bQ3ªºÀç·~§Q¼í¦~¼W226%¡A¹F¨ì2.8»õÁú¤¸¡]¬ù·s¥x¹ô675»õ¡^¡C
--------------------------------------------------------------------------------------------------
¨k©È¤J¿ù¦æ¡A¤k©È¶ù¿ù¦¡C
¤¤ªo»P¨È¾F¦U°êµ|«á¹s°â»ù¤ñ¸ûªí
¸ê®Æ§ó·s¤é´Á:2023/1/1
92¨Tªo(¤¸/¤½¤É) 95¨Tªo(¤¸/¤½¤É) ¶W®ã(¤¸/¤½¤É)
Áú°ê 37.03 44.82 41.72
¤é¥» 38.74 N/A 34.15
·s¥[©Y N/A 62.24 60.87
»´ä N/A N/A 82.71
¤¤ªo 29.5 31 27.8
¦]¬°426¦h¬OµL®¢ªº¤ñ¨Ò°ª¡A¤£µM§Ú̪ºTFT·|³oºG¡Cè¶}©l·s¥x¹ú´«¤HÀY¯È¡A«á¨Óªºµ²§½´NGG¤F¡C
´N©M¦L«×»sÃĤ@¼Ë¡A¤H¥Án¬¡¤U¥h¡C
=====================
»P¤¤°ê¥æ¬yÁÙ¬Onª`·NÅѨú问ÃD¡A¹ï¤è¬F©²ªk°|°¾³R´N§i¤£°Ê¤F¡F810¬Ý±o¥X¨Ó¤´¥H¤jÃļt¬°Àu¥ý¦Ò¶q¡A°£¨º¨â®a¥~¼È®É¨S¦³»P§O®a½Í±ÂÅv¡C·sªº¤@¦~¦V¦UªÑ¤Í¤j¤j«ô¦~½Ð¦w¡F¤@¦~¨ÓªYÄ£¤]ª§®ðº¦¤F3¦¨¡A¹ï¤ñ¤W¥«½Lºâ«ÜÀu¨q¡I¥¼¨Ó¤@¦~¤×¨ä¤W¥b¦~¤Ñ¤Ñ¥Rº¡¾÷·|¡A¬Û«H·sªº¤@¦~³ø¹S²v¤@©w¤ñ¤µ¦~3¦¨°ª¡C
¨CÓ²£·~³£¤@¼Ë¡A¤j¥ß¥ú¬O¥ú学ªº翘·¡~~~~~~~~~
¬ü°ê¥qªk³¡¤W¶g¥|¡]26¤é¡^ªí¥Ü¡A¥Íª«»sÃĪì³Ð¤½¥q¡u³ß±d¥Í§Þ¡v¡]JHL Biotech¡^¨â¦WÁp¦X³Ð©l¤H¡A©Ó»{¦@¿ÑÅѨú¬ü°ê¥Í§Þ¥¨ÀY¤½¥q¯A¶û窃¨ú¦³关°ò¦]®õ§J°Ó·~¾÷±K¤Î¯A¶û¶W¹L1.01»õ¬ü¤¸¹q«H´Û¶Bªº¸o¦æ¡C
³ß±d¬O¤£¬O¬°¤F½ß¿ú½â½æ¸ê²£?!
=====================================
·sÃĦ³µÛÃe¤j§Q¯q¡A¤j³°¤£¬O°_ÀYªÌ¡A©¹«e¨ì1991¦~ªº°ò¦]¤½¥qGenentech´N¬O³o¼Ë·d±i¤l¤å³Õ¤hªº¡u¼ÖµL³Ý¡vÃÄ!